Hypoxia-induced lncrna rbm5-as1 promotes tumorigenesis via activating wnt/β-catenin signaling in breast cancer

HIGHLIGHTS

• who: Xinping Li from the Clinical samples from patients We obtained patient samples from Jiangsu Provincial Breast Disease Center, First Affiliated Hospital of Nanjing Medical University (Nanjing, China), all the specimen collection informed patients and had their written consentThe Ethical Review Committees in China Pharmaceutical University (Nanjing, China) ethically approved our study, which was performed in accordance with the Helsinki Principles Declaration. Reviewed by practiced clinical pathologists, tumor sample histology and biopsy were used as the basis for pathological diagnosis. Pathological characteristics of the clinical samples can be found in supplementary documents (Table, ) and the breast cancer . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.